Submission Guidelines

XX AMNET International Conference: Surveillance, promotion, and Care for People with chronic illnesses

13th, 14th, and 15th September 2023, Porto Alegre, Brazil.

Guidelines for abstract submission

I. Requirements

Professionals, students, non-governmental organization members, and researchers in the health field and associated areas are eligible for abstract submission.

At least one of the authors must be registered at the conference to present the abstract.

II. Abstract presentation model:

Abstracts will be presented in poster format or oral presentations. The reviewers will select the abstracts that will go for oral presentation. Authors will be notified until August 31, 2023. Abstracts must follow the template provided by the event organizers.

III. Timeline

Opening date to receive abstracts: June 26, 2023.

Deadline to receive abstracts: August 17th, 2023, until 11:59 p.m. (Brasilia time, Brazil). Only abstracts submitted by this date and time will be accepted for review.

Abstract poster acceptance notification date: August 31, 2023.

Oral presentation acceptance notification date: August 31, 2023.

IV. Formatting

Please use the following guidelines to prepare your abstract:

All abstracts must be submitted through the online submission system.

All abstracts must be written in English, Spanish, or Portuguese.

Select a primary and secondary topic area from the list, which will be used to organize concurrent contributed sessions.

The abstract should not exceed 250 words (Title and author information are not included in the 250 words limit).

The number of abstracts per author will not be limited.

Do not include references or mathematical equations in the abstract.

Avoid non-familiar acronyms and, where necessary, spell them out when used for the first time (standard abbreviations in epidemiology such as OR, RR, RD, and CI do not need to be spelled out).

Works developed only under graduation must select the category "undergraduate works", with a professor coordinating, when submitting the abstract.

Studies in humans must be approved by the Research Ethics Committee, except those using public data and studies with animals by the Committee on Ethics in the Use of Animals.

Text Formatting

Submission document format: abstracts should be submitted in docx format (Word 2007 or higher) or doc format (older Word versions).

Document size: A4.

Document margins: 2.54 cm (upper, lower, left, and right).

Abstract title font type and size: use 12- point Calibri font, bold, and aligned to the left.

Abstract text font type and size: use 10-point Calibri font and justify.

Correspondence author font type and size: use 10- points Calibri font.

Authors' filiation font type and size: use 9- points Calibri font and align to the left.

Authors' names: Surname(s) followed by the name(s). The author's information must be complete and separated by semicolons, Calibri 10 points, bold, and aligned to the left.

Corresponding author information: please, indicate at least one corresponding author per work with the full name and email.

Keywords: please, include three to five relevant keywords after the abstract. We recommend that the keywords are specific to the abstract but reasonably common within the subject discipline (you can use MeSH and DeCS terms).

Units: Use the units of the international system (SI). If other units are mentioned, give their equivalent in the SI.

References: References should not be included.

General abstract structure: The abstract structure should follow the subheadings objectives, methods, results, and conclusion, as suggested below.

Epidemiological studies:

Title: should be related to the primary research objective and describe the research design (e.g., cohort, case-control, cross-sectional)

Objectives: This section should state the precise objective or study question addressed in the project (e.g., "To determine whether…").

Descriptive: ideally using the PEO (an acronym for P: population/patients; E: exposition; O: outcome/outcome).

Analytic studies: ideally, it should use the PICO (an acronym for P: population/patients; I: intervention; C: comparison/control; O: outcome/outcome) or PECO (an acronym for P: population/patients; E: exposition; C: comparison/control; O: outcome/outcome).

If more than one objective is addressed, the main objective should be indicated, and only critical secondary objectives should be stated. If an a priori hypothesis was tested, it should be stated.

Methods:

Study design: describe the research design (e.g., cohort, case-control, cross-sectional).

Setting: Description of setting, follow-up dates or dates at which the outcome events occurred or at which the outcomes were present, and any points or ranges on other time scales for the outcomes (e.g., prevalence at age 30, 2000-2023).

Participants: A cohort study—Give the most important eligibility criteria and the most important sources and methods of selection of participants. Briefly describe the methods of follow-up.

Case-control study—Give the major eligibility criteria and the major sources and methods of case ascertainment and control selection.

Cross-sectional study—Give the eligibility criteria and the major sources and methods of selection of participants.

Variables: describe how variables were collected and classified when applied.

Intervention, clinical trials only: The experimental and control interventions for each group with sufficient details to allow replication, including how and when they were administered. In clinical trials, also include a description of randomization and blinding, when applicable.

Data analysis: describe the process of defining and analyzing the data, if applicable.

Results:

Participants: Report the number of participants at the beginning and end of the study and their characteristics.

Main results: Report the participant's estimates of associations, if applicable. Consider translating relative risk estimates into absolute risk for a meaningful time if relevant. Report appropriate measures of variability and uncertainty (e.g., odds ratios with confidence intervals). Approaches such as the number needed to treat to achieve a unit of benefit may be included when appropriate. Studies of screening and diagnostic tests should report sensitivity, specificity, and likelihood ratios. If predictive value or accuracy is reported, prevalence or pretest likelihood should be given as well. All randomized controlled trials should include the results of intention-to-treat analysis, and all surveys should include response rates.

Conclusions:

The conclusion should describe a general interpretation of the study results. Provide only findings of the study directly supported by the objective results, along with implications for clinical practice, avoiding speculation and over-generalization. Indicate whether additional research is required before the information should be used in usual clinical settings. Give equal emphasis to positive and negative findings of equal scientific merit.

Qualitative studies: Title: Concise description of the nature and topic of the study Identifying the study as qualitative or indicating the approach (e.g., ethnography, grounded theory) or data

Objectives:

This section should state the precise objective or study question addressed in the research.

Methods:

Methodological Orientation and Theory: What methodological orientation was stated to underpin the study? e.g., grounded theory, discourse analysis, ethnography, phenomenology, content analysis

Participant selection

Sampling: How were participants selected? e.g., purposive, convenience, consecutive, snowball;

Method of approach: How were participants approached? e.g., face-to-face, telephone, mail, email

The setting of data collection: Where was the data collected? e.g., home, clinic, workplace

Data collection: Were questions, prompts, and guides provided by the authors? Was it pilot tested?

Units of study: Number and relevant characteristics of participants, documents, or events included in the study; level of participation (could be reported in results)

Data analysis: analysis description and software used.

Results:

Synthesis and interpretation: Main findings (e.g., interpretations, inferences, and themes); might include the development of a theory or model or integration with prior research or theory.

Conclusions:

A summary of main findings; explanation of how findings and conclusions connect to, support, elaborate on, or challenge conclusions of earlier scholarship; discussion of the scope of application/ generalizability; identification of unique contribution(s) to scholarship in a discipline or field.

Systematic or scoping reviews:

Title: should be related to the primary research objective and describe the research design (e.g., systematic review, systematic review, and meta-analysis or scoping review)

Objectives:

This section should state the precise objective or study question addressed in the project (e.g., "To determine whether…").

Descriptive: ideally using the PEO (an acronym for P: population/patients; E: exposition; O: outcome/outcome).

If more than one objective is addressed, the main objective should be indicated, and only key secondary objectives should be stated. If an a priori hypothesis was tested, it should be stated.

Eligibility criteria: Specify characteristics of the sources of evidence used as eligibility criteria (e.g., years considered, language, and publication status), and provide a rationale.

Information sources: Describe all information sources in the search (e.g., databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed.

Selection of sources of evidence: State the process for selecting sources of evidence (i.e., screening and eligibility) included in the scoping review.

Risk of bias: Specify the methods used to assess the risk of bias in the included studies.

Synthesis of results: Specify the methods used to present and synthesize results.

Results:

Included studies: Give the total number of included studies and participants and summarise relevant characteristics of studies.

Synthesis of results: Present results for primary outcomes, preferably indicating the number of included studies and participants. Report the summary estimate and confidence/credible interval if a meta-analysis was done. If comparing groups, indicate the direction of the effect (i.e., which group is favored).

Conclusions:

Provide a general interpretation of the results and important implications.

IV. General information

All accepted abstracts will be published on the Congress website (ISSN: 2833-3640) with an official DOI number.

The Scientific Committee of the Conference will be not responsible for not receiving works attributable to submission errors, Internet problems, hardware or software delays, power outages, or other factors outside the organization.

Each author must ensure that their work has been received correctly. Once your abstract has been received, you will receive a confirmation email.

V. Abstract evaluation criteria:

I. Originality and relevance of the study. II. Objectives

This section should state the precise objective or study question addressed in the research.

III. Methods The study design is consistent with the objective(s).

Participants' information, sampling method, and inclusion and exclusion criteria are included.

Description of exposure & outcome variable, information on co-variates. Information on data analysis

V. Results

The results respond to the objectives set.

The results are presented in a well-structured and summarized way. Results include the magnitude of associations, confidence intervals, and/or p-values for quantitative studies, if applicable.

The data is sufficient, and its presentation allows the reader to conclude.

V. Conclusions

They are consistent with the objectives and results.

IV. General abstract rules

The authors followed the instructions regarding the submission of the Congress abstract.

If you have any questions, please contact:

Conference Office: amnetconferencias@gmail.com